STOCK TITAN
  1. Home
  2. Sec-filings
  3. XAGE
  4. [8-K] Longevity Health Holdings, Inc. Reports Material Event

Director Kathryn Gregory exits Longevity Health Holdings (XAGE) board without dispute

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Longevity Health Holdings, Inc. reported a change in its Board of Directors. On June 1, 2026, Kathryn Gregory notified the company that she was resigning from the Board, effective at the close of business that same day. The company states that her resignation was not due to any disagreement regarding its operations, policies, or practices, indicating a routine governance change rather than a dispute-driven departure.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Resignation effective date June 1, 2026 Effective at close of business
Item 5.02 regulatory
"Item 5.02. Departure of Directors or Certain Officers; Election of Directors"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Board of Directors financial
"resignation from the Board of Directors of the Company"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Chief Financial Officer financial
"Bryan J. Cassaday | | | | Chief Financial Officer"
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
0001842939<empty>00018429392026-06-012026-06-01

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 1, 2026

 

 

Longevity Health Holdings, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40228

86-1645738

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2403 Sidney Street, Suite 300

 

Pittsburgh, Pennsylvania

 

15203

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (412) 894-8248

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 1, 2026, Kathryn Gregory notified Longevity Health Holdings, Inc. (the “Company”) of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026.

 

Ms. Gregory’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

LONGEVITY HEALTH HOLDINGS, INC.

 

 

 

Dated: June [*], 2026

By:

/s/ Bryan J. Cassaday

 

 

Bryan J. Cassaday

 

 

Chief Financial Officer

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What board change did Longevity Health Holdings (XAGE) disclose in this 8-K?

Longevity Health Holdings disclosed that director Kathryn Gregory resigned from its Board, effective at the close of business on June 1, 2026. The company indicated her resignation was not due to any disagreement over operations, policies, or practices.

When did Kathryn Gregory’s resignation from Longevity Health Holdings (XAGE) become effective?

Her resignation became effective at the close of business on June 1, 2026. This means she ceased serving as a director at the end of that business day, following notice provided to Longevity Health Holdings on the same date.

Did Kathryn Gregory resign from Longevity Health Holdings (XAGE) due to a disagreement?

No, the company states that Kathryn Gregory’s resignation was not the result of any disagreement with Longevity Health Holdings. This covers matters related to its operations, policies, or practices, suggesting a non-contentious transition.

Which SEC item does the Longevity Health Holdings (XAGE) filing relate to?

The filing relates to Item 5.02, which covers departures and appointments of directors or certain officers and compensatory arrangements. Here, it specifically reports the resignation of director Kathryn Gregory from the Board of Longevity Health Holdings.

Who signed the Longevity Health Holdings (XAGE) 8-K reporting the director resignation?

The 8-K was signed on behalf of Longevity Health Holdings by Bryan J. Cassaday, who serves as the company’s Chief Financial Officer. His signature indicates the company’s authorization and responsibility for the disclosure.

Filing Exhibits & Attachments

1 document

Other Documents